Hughes & Company

What Hughes & Company does

Hughes & Company is a Chicago-based private equity firm founded in 2011 that invests exclusively in lower middle market healthcare software and technology-enabled service companies. The firm invests $5 million to $50 million+ per company through growth equity, leveraged buyouts, spin-outs, and strategic combinations, working as an active, hands-on investor focused on accelerating revenue and EBITDA growth, expanding margins, and enhancing customer value propositions at portfolio companies. Its current portfolio spans six active platforms: Azara Healthcare (population health management), Encoda (revenue cycle management for specialty physician practices), Valer (prior authorization automation, formerly Voluware), LifeLoop (senior living engagement software), Health Data Innovations (healthcare data integration for value-based care), and the merged Curvo/BroadJump platform (hospital spend management and analytics). Notable exits include Aldera (sold to Evolent Health, 2016) and Aperture Credentialing (sold to Stone Point Capital, 2021), with majority recapitalizations of Azara (Insight Partners, 2024) and LifeLoop (Vista Equity Partners, 2022).

The firm operates as a limited partnership (Hughes & Company Investment Partners, L.P.) and closed its first private equity fund, Hughes Growth Equity Fund I, L.P., at $116 million in July 2021, exceeding its $100 million target. Hughes does not develop proprietary technology itself — its investment thesis depends on identifying and supporting healthcare software companies with demonstrated business models, then providing institutional best practices, business development, team building, and shared operating expertise. The five-person Managing Partner team combines healthcare operator backgrounds (founders/operators of Navicure/Waystar, Curaspan/Navihealth, MedInitiatives/IQVIA) with PE experience from JMI Equity, Wind Point Partners, Francisco Partners, and New Leaf Venture Partners.

Revenue mechanics follow standard PE fund economics: management fees on committed capital under management plus performance-based carried interest from successful portfolio exits (typically 20% above a hurdle rate). Deal sourcing relies on direct industry networks, intermediary relationships, and proactive business development, distributed through a professional website, LinkedIn presence, and press releases. The firm maintains a lean 1-10 employee structure with offices in Chicago, supporting its concentrated vertical focus in healthcare technology investing.

Name

Hughes & Company

Legal name

Hughes & Company

Website

https://hughes-co.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Hughes & Company is a Chicago-based private equity firm investing $5M-$50M+ exclusively in lower middle market healthcare software and technology-enabled service companies. The firm operates as an active investor across a portfolio of six healthcare tech platforms.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity Investment Management

NAICS

Portfolio Management and Investment Advice (52394)

SIC

Investment Advice (6282)

akta.pro primary industry

Technology & Software Growth Equity (FSANACAA)

Keywords

• Healthcare private equity
• Growth equity investing
• Healthcare software investment
• Portfolio company management
• Technology-enabled services investing

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Fund Management Fees: Private equity firms typically charge management fees on committed capital under management, though specific fee structures are not publicly disclosed.
2. Carried Interest: Performance-based carried interest from successful portfolio company exits, typically 20% of profits above a hurdle rate.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Hughes & Company is a private equity firm that invests growth capital ($5 million to $50 million+ per company) in lower middle market healthcare software and technology-enabled service companies. The firm serves as an active investor, providing capital alongside operational support, business development, team building, and shared best practices to help portfolio companies accelerate revenue and EBITDA growth, expand margins, and enhance customer value propositions. Investment structures include minority and majority control transactions, growth equity, leveraged buyouts, spin-outs, and strategic combinations.

Product overview

Hughes & Company is a private equity firm focused exclusively on lower middle market healthcare software and technology-enabled service companies. Rather than offering a unified product platform, the firm manages a portfolio of distinct portfolio company products spanning population health management, revenue cycle management, prior authorization, senior living engagement, healthcare credentialing, and supply chain analytics. Key portfolio products include Azara Healthcare's population health management platform, Encoda's revenue cycle management technology and services, Valer's prior authorization platform (formerly Voluware), LifeLoop's senior living software platform, Health Data Innovations' data integration platform, and the combined Curvo/BroadJump spend management platform. Hughes & Company creates value through business development, team building, resource optimization, and shared operating best practices rather than through a consolidated product architecture.

Differentiator

Problem solved

Functional benefit

Products and services

• Hughes Growth Equity Fund I, L.P. The firm's flagship private equity fund that invests in lower middle market healthcare software and technology-enabled service companies, offered to qualified limited partner investors (family offices, endowments, pension funds) through private placement.
• Growth Equity Investments Minority and majority growth equity capital investments ($5 million to $50 million+ per company) in healthcare software and technology-enabled service companies with demonstrated business models seeking to accelerate growth, expand margins, and enhance customer value propositions.
• Leveraged Buyouts Leveraged buyout transactions in lower middle market healthcare software and technology-enabled service companies, structured as control investments with active operational involvement.
• Spin-outs and Strategic Combinations Investment services supporting corporate spin-outs and strategic combinations in the lower middle market healthcare software and technology-enabled service sectors.
• Active Portfolio Company Support Hands-on operational support service for portfolio companies covering business development, team building, resource optimization, shared operating best practices, and application of institutional best practices to drive revenue and EBITDA growth.

Quantifiable outcome

• Portfolio companies receive growth capital and operational support to accelerate growth and scale into market leaders

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Aledade and Azara HealthcarecoreStrategic or Co-development Partner · 16 July 2024Aledade (nation's largest network of independent primary care) and Azara Healthcare (Hughes & Company portfolio company, Best in KLAS provider) announced a partnership to empower community health centers to thrive under value-based care arrangements.
• Azara Healthcare and NetsmartcoreStrategic or Co-development Partner · 24 April 2024Azara Healthcare and Netsmart (industry-leading healthcare IT company and population health management platform provider) announced a pilot collaboration with healthcare providers in Missouri to share patient data between care settings, increasing continuity of care across behavioral health and primary care.
• Azara Healthcare and Equality HealthcoreStrategic or Co-development Partner · 26 March 2024Azara Healthcare (Best in KLAS provider of population health management and value-based care solutions) and Equality Health (national leader in value-based care) announced a joint solution enabling Community Health Centers to thrive in risk-based arrangements.
• Valer and EncodacoreStrategic or Co-development Partner · 14 March 2024Valer (industry-leading prior authorization and referral management automation technology) and Encoda (Hughes & Company portfolio company, leading claims and denials software solution) announced a strategic partnership to help bridge the gap in prior authorization and healthcare revenue integrity among mid to large healthcare organizations.
• Encoda and VeradigmminorChannel Partner/ Reseller/ Distributor · 26 September 2023Encoda LLC announced collaboration with Veradigm as a Channel Partner. Encoda integrates Encoda BackOffice and Encoda Maestro Analytics with Veradigm's Practice Management software to automate manual processes for medical billers while providing actionable revenue cycle insight.
• iN2L and Christian Living CommunitiesminorStrategic or Co-development Partner · 4 February 2020iN2L (It's Never 2 Late) and Christian Living Communities (Denver-based not-for-profit specializing in senior care and services) entered a strategic partnership to improve the social determinants of health in older adults through person-centered digital engagement technology.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Welsh, Carson, Anderson & Stowe: Large healthcare and technology-focused PE firm with a dedicated healthcare practice investing across services, IT, and devices. A larger incumbent that competes for healthcare growth equity deals, often at the upper end of Hughes & Company's deal size range.
• Francisco Partners: Technology-focused private equity firm with a dedicated healthcare technology practice. Comparable in its pursuit of healthcare software buyouts and growth investments, though typically at larger check sizes and broader mandate.
• Vista Equity Partners: Global technology-focused private equity firm that has been a co-investor and recapitalization partner for Hughes & Company (e.g., LifeLoop 2021). A larger incumbent in enterprise software and healthcare IT buyouts.
• New Mountain Capital: Large growth-oriented investment firm with a major healthcare information and services franchise. A broad incumbent that frequently invests in healthcare software and tech-enabled services companies similar to Hughes & Company's portfolio.
• Insight Partners: Global software-focused investment firm that led the Azara/i2i merger in 2025. A large-scale incumbent in growth and buyout investing across healthcare and enterprise software.

Direct peers

• SV Health Investors: Healthcare growth equity and venture firm investing across healthcare services and technology with a growth-stage focus. Comparable in dedicated healthcare mandate and growth equity orientation, with a US/UK footprint.
• Linden Capital Partners: Healthcare-focused private equity firm investing in middle market healthcare companies across services, products, and technology. Comparable healthcare-only mandate and lower middle market orientation.
• Anthem Capital Partners: Middle market private equity firm focused on healthcare services and technology-enabled services. Comparable in healthcare TES vertical focus and lower middle market check sizes.
• Primus Capital: Growth equity firm with a dedicated healthcare technology and services practice investing in lower middle market companies. Highly comparable on vertical focus and stage/check size to Hughes & Company.
• Galen Partners: Healthcare-focused growth equity firm investing in lower middle market healthcare technology and services companies. Directly comparable in sub-sector focus (healthcare software/TES) and check size relative to Hughes & Company.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hughes-and-company

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hughes & Company